How should a salbutamol metered‑dose inhaler be used in a 4‑year‑old child with a history of wheeze who stopped inhaled therapy two months ago and now presents with a cough but no wheeze on examination?

How to Use Salbutamol Inhaler in This 4-Year-Old Child

This child should receive salbutamol via a metered-dose inhaler (MDI) with a large volume spacer device, using 2 puffs (200 mcg total) as needed for symptom relief, with the option to repeat every 4-6 hours if cough persists or worsens. 1, 2

Device Selection and Technique

Use an MDI with a large volume spacer—this is the appropriate delivery system for a 4-year-old child. 1

• Most children at age 4 cannot achieve the coordination necessary to use an unmodified MDI, and this should not be used unless there is certainty about the child's technique 1
• Large volume spacer devices are more efficient than nebulizers, which are overused in both hospital and community settings 1
• The spacer technique involves: actuate the MDI, breathe in one puff, repeat the actuation, then breathe in the second puff, continuing until the appropriate number of puffs has been inhaled 1

Dosing Strategy

Start with 2 puffs (200 mcg total) as needed when symptoms occur. 2

• The FDA-approved dosing for children 4 years and older is 2 inhalations repeated every 4-6 hours for acute episodes of bronchospasm 2
• More frequent administration or a larger number of inhalations is not recommended 2
• The doses for the 3-4 year age group are maximal doses; often smaller amounts will suffice 1
• Relief treatment can be repeated 2-4 hourly outside hospital, but failure to respond or early deterioration requires immediate medical assessment 1

Clinical Context and Reassessment

The absence of wheeze on examination does not exclude asthma—recurrent cough is a recognized asthma symptom in children. 1

• Cough, especially if recurrent, is a key presenting feature of asthma in children 1
• Night time disturbance by cough is particularly significant 1
• The child's history of known wheeze and previous inhaler therapy suggests underlying asthma 1

Before escalating therapy, ensure proper inhaler technique and reassess the diagnosis. 1

• The diagnosis should be reviewed and confirmed 1
• Verify that the family understands how and when to use the medication 1
• Assess whether the child is using an inhaler appropriate for their age with good technique 1

When to Consider Additional Treatment

If salbutamol as needed does not provide adequate control, consider restarting controller therapy rather than increasing bronchodilator frequency. 1

• If a previously effective dose regimen fails to provide the usual response, this may indicate destabilization of asthma and requires reevaluation, with special consideration for anti-inflammatory treatment (e.g., inhaled corticosteroids) 2
• Inhaled corticosteroids are the mainstay of preventive treatment for children with persistent symptoms 1
• The outcome of successful management should be minimal symptoms during the day, no waking at night, and relatively infrequent need for relief medications 1

Parent Education and Follow-Up

Provide oral and written instructions on proper use, when to seek help, and environmental trigger avoidance. 1

• Parents should understand the difference between bronchodilators ("relievers") and anti-inflammatory treatment ("preventers") 1
• They should know when to call for help if symptoms worsen 1
• Environmental control is important, especially avoiding cigarette smoke exposure 1
• The mouthpiece should be washed and dried thoroughly at least once weekly to prevent medication buildup and blockage 2

Common Pitfalls to Avoid

• Do not use nebulizers routinely—they are expensive, time-consuming, and inefficient compared to MDI with spacer 1, 3, 1
• Do not give an unmodified MDI without a spacer to a 4-year-old 1
• Do not delay reassessment if the child requires frequent salbutamol use—this indicates poor control and need for controller therapy 1, 2
• Recent evidence suggests that as-needed dosing after initial stabilization may be safer and more effective than fixed-dose weaning regimens, with lower salbutamol exposure and comparable outcomes 4, 5, 6